FR2635682A1 - Cosmetic composition for application to the skin for reducing the burning sensation on shaving or depilation - Google Patents
Cosmetic composition for application to the skin for reducing the burning sensation on shaving or depilation Download PDFInfo
- Publication number
- FR2635682A1 FR2635682A1 FR8811318A FR8811318A FR2635682A1 FR 2635682 A1 FR2635682 A1 FR 2635682A1 FR 8811318 A FR8811318 A FR 8811318A FR 8811318 A FR8811318 A FR 8811318A FR 2635682 A1 FR2635682 A1 FR 2635682A1
- Authority
- FR
- France
- Prior art keywords
- shaving
- skin
- composition according
- product
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/002—Aftershave preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q9/00—Preparations for removing hair or for aiding hair removal
- A61Q9/02—Shaving preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
La présente invention a trait au domaine des compositions cométiques destinées à être appliquées sur la peau lors de brûlures ou échauffements. Elle concerne plus spécialement des compositions permettant de supprimer ou réduire les sensations de brûlure et les douleurs au moment du rasage chez l'homme et de l'épilation chez la femme. The present invention relates to the field of cometic compositions intended to be applied to the skin during burns or overheating. It relates more particularly to compositions making it possible to suppress or reduce the burning sensations and the pains at the time of shaving in men and hair removal in women.
La prévention de la douleur cutanée ou le traitement de cette dernière font généralement appel, à ce jour, à des compositions dermiques contenant des anesthésiques locaux tels que par exemple le butoforme, i'éthoforme ou autres produits à fonction équivalente. The prevention of skin pain or the treatment of the latter generally use, to date, dermal compositions containing local anesthetics such as for example butoform, ethoform or other products with equivalent function.
Les anesthésiques de contact présentent souvent l'inconvénient d'ent!ner une sensibilisation générale et non simplement locale comme désiré. En outre, ils sont fréquemment responsables de réactions allergiques dont les degrés de gravité peuvent passer de la simple dermite au choc anaphylactique. Contact anesthetics often have the disadvantage of general awareness, not just local awareness, as desired. In addition, they are frequently responsible for allergic reactions, the severity of which can range from simple dermatitis to anaphylactic shock.
L'invention a pour but d'obvier à ces inconvénients et de proposer des formulations cosmétiques ne provoquant pas d'irritations cutanées et particulièrement avantageuses pour prévenir les douleurs éprouvées lors des séances d'épilation et/ou du rasage tant du visage que d'autres membres de l'organisme chez les deux sexes. The object of the invention is to obviate these drawbacks and to propose cosmetic formulations which do not cause skin irritations and which are particularly advantageous for preventing the pains experienced during epilation and / or shaving sessions both on the face and on the face. other members of the body in both sexes.
I1 a en effet trouvé, de façon surprenante et inattendue, après de nombreux travaux de recherches et d'expérimentations, que l'hydroxypolyéthoxydodécane (H.D.P) -produit connu pour ses propriétés d'agent tensioactif non ionique- possédait une action anesthésique et analgésique locale s'opposant favorablement à la douleur due au "feu du rasoir" ou à celle éprouvée lors de l'épilation de certains membres du corps humain. He indeed found, surprisingly and unexpectedly, after numerous research and experimental works, that hydroxypolyethoxydodecane (HDP) - product known for its nonionic surfactant properties - possessed a local anesthetic and analgesic action opposing favorably the pain due to "razor burn" or to that experienced during the epilation of certain members of the human body.
I1 a en outre été constaté que cet effet sédatif sur la douleur, laquelle se manifeste par une sensation de rougeur et de souffrance cutanée, était encore renforcé lorsque le produit actif susvisé était associé à un agent de pénétration adéquat dénommé ici promoteur d'absorption cutanée. I1 was also found that this sedative effect on pain, which is manifested by a feeling of redness and pain in the skin, was further enhanced when the abovementioned active product was combined with an adequate penetration agent called here promoter of skin absorption. .
L'invention a donc pour objet une nouvelle composition cosmétique contenant, outre les ingrédients et excipients classiques, de l'hydroxypolyéthoxydodécane comme produit actif, avantageusement associé å un promoteur d'absorption cutanée. The subject of the invention is therefore a new cosmetic composition containing, in addition to the conventional ingredients and excipients, hydroxypolyethoxydodecane as active product, advantageously combined with a skin absorption promoter.
Parmi les promoteurs susvisés, on peut citer tout spécialement des sels d'alcoylarylammoniums et,-parmi ceux-ci, des saccharinates d'alcoyldiméthyl bézylammoniums. De telles substances augmentent sensiblement le pouvoir de pénétration de 1'H.D.P. au lieu d'application et favorisent une action rapide et durable. Contrairement au cas des anesthésiques locaux dont l'effet fugace s'explique par la destruction hydrolytique des promoteurs d'absorption cutanée, 1'H.D.P. ne subit pas de métabolisme pouvant diminuer son action au niveau des couches dermiques traitées. Among the aforementioned promoters, mention may be made especially of alkylarylammonium salts and, among these, alkyl dimethylbezylammonium saccharinates. Such substances significantly increase the penetrating power of H.D.P. instead of application and promote rapid and lasting action. Contrary to the case of local anesthetics whose fleeting effect is explained by the hydrolytic destruction of the skin absorption promoters, 1'H.D.P. does not undergo metabolism which can reduce its action in the treated dermal layers.
Dans la formulation des compositions selon l'invention, on met en oeuvre, bien entendu, en dehors des constituants actifs susvisés, les ingrédients et excipients classiques tels que agents de mise en suspension, excipients lipidiques, agents conservateurs, parfum ou essence non allergique, etc. Lors des formulations, la quantité de 1'H.D.P. peut varier généralement de 1 à 10 % et celle du promoteur d'absorption entre 0,01 et 0,05 X en en poids de la composition totale). In the formulation of the compositions according to the invention, it is used, of course, apart from the abovementioned active constituents, the conventional ingredients and excipients such as suspending agents, lipid excipients, preserving agents, perfume or non-allergic essence, etc. During formulations, the amount of H.P. can generally vary from 1 to 10% and that of the absorption promoter between 0.01 and 0.05 X by weight of the total composition).
En pratique, de telles compositions actives peuvent être présenter sous diverses formes liquides, semi-solides ou solides, telles que notamment : suspension visqueuses, lotions hydro-alcooliques, crèmes dermiques, gels, baume, mousses aqueuses...etc. In practice, such active compositions can be present in various liquid, semi-solid or solid forms, such as in particular: viscous suspension, hydro-alcoholic lotions, dermal creams, gels, balm, aqueous foams, etc.
A titre purement illustratif, on décrira ci-après quelques exemples non limitatifs de formulations qui entrent dans le cadre de l'invention. Purely by way of illustration, a few nonlimiting examples of formulations which fall within the scope of the invention will be described below.
Sauf indications contraires, les pourcentages des produits sont indiqués en poids.Unless otherwise indicated, the percentages of the products are given by weight.
Exemple 1
Crème dermique comprenant - 0,5 g % d'hydroxypropylméthylcellulose - 5,0 g X d'hydroxypolyéthoxydodécane (ou H.D.P) - 10,0 g % de propylène glycol - 2,0 g % d'alcool cétylique - 0,025 g X de saccharinate d'akoyldiméthylbenzylammonium - 0,6 g % de conservateur connu "GERMAL Il" (marque deposée)
Exemple 2
Gel dermique transparent comprenant - 5,0 g X d'H.D.P - 0,6 g % de polymère carboxyvinylique - 2,0 g X de silicate de magnésium-aluminium colloidal - 1,0 g % de polymère d'oxyéthylène - qsq PH 4,5 d'hydroxyde de sodium 1N - 5,0 g % d'H.D.P - 0,025.g % de saccharine d'aRbyldiméthylbenzylammonium - 0,5 g % de conservateur connu "Nuosept C" (marque déposée) - qsp 100 X d'eau purifiée
Exemple 3
Lotion hydro-alcoolique comprenant - 5,0 g % d'H.D.P - 0,03 g % de saccharinate d'alroyl diméthylbenzylammonium - 4,9 g % de glycéride d'acide caprique (ester caprique de polyoxyéthylène
glycol) - 1,5 g % de glycérine - 35,0 g % d'eau purifiée - 0,5 g % d'acide citrique - 58,0 g d'alcool à 960 - 0,6 g % de conservateur Germal II - parfum qs pour 100 %
Exemple 4
Crème dermique comprenant - 5 g % d'H.D.P - 0,025 g % de saccharinate d'akcyldiméthylbenzylammonium - 6 g % de lauryléther polyoxyéthylène (type laureth-23) - 2 g % de polymère carboxyvinylique - 2 g % d'oxyde de titane - 5 g % d'acétone - 0,5 g % de conservateur NuoseptC - qsq PH 4,5 de triéthanolamine - qsp 100 % d'eau purifiée
Exemple 5
Suspension aqueuse comprenant - 5 g % d'H.D.P - 1 g % de propylèneglycol - 2 g % de diéthanolamide d'acide gras de coco - 0,025 g % de saccharinate draR yldiméthylbenzylammonium - 0,8 g % de silicate de magnésium et d'aluminium - 0,9 g % de chlorure de sodium - l g % d'hydroxypropylméthylcelîulose - 0,5 g X de conservateur Nuoseptic - qsp 100 % d'eau distillée
Exemple 6 Crème à raser moussante de composition - 5,0 g X d'H.D.P - 20,0 g X d'acide stéarique - 10,0 g % d'acide laurique - 2,0 g X d'hydroxyde de sodium - 1,0 g % d'hydroxyde de potassium - 10,0 g % de glycérine - 1,0 g % de lanoline - 2,0 g X d'huile végétale - 0,5 g X d'imidazolidinylurée (conservateur) - qsg eau purifiée 100 g
Exemple 7
Baume à raser comprenant - 5,0 g % d'H.D.P - 0,025 g X de saccharinate d'al0oyl diméthylbenzyl ammonium - 7,0 g % d'huile d'arachide - 0,66 g % de parfum - 0,4 g % de triéthanolamine l,l g % d'ammoniaque - 16.6 g % de stéarine - qsp 100 % d'eau purifiée Exemplt 8 : :
Lotion hydroalcoolique comprenant - 5,0 g % d'H.D.P - 0,6 g X de conservateur Germal II - 5,0 g X d'Ameroxol OE 10 (alcool oléique méthoxylé) - 2,5 g X de Glucam E 20 (glucoside niethoxyle) - 45.0 g X d'alccol éthylique 950 qsp 100 X d'eau purifiée
exemple 9
Nous se aqueuse contre le feu du rasoir comprenant
- 1,25 g de pistocstne (oxy-polyéthoxydodécane)
- 1,00 g d'acide stéarique
- 0,50 g de triethanolamime
- 0,90 g de cire de Lanol CTO
- 5 g de fréon (mélange 40/60 de fréon 12 et fréon 114)
- qsp 100 Z soit 25 g d'eau purifiée. Example 1
Dermal cream comprising - 0.5 g% of hydroxypropylmethylcellulose - 5.0 g X of hydroxypolyethoxydodecane (or HDP) - 10.0 g% of propylene glycol - 2.0 g% of cetyl alcohol - 0.025 g X of saccharinate akoyldimethylbenzylammonium - 0.6 g% of known preservative "GERMAL II" (registered trademark)
Example 2
Transparent dermal gel comprising - 5.0 g X of HDP - 0.6 g% of carboxyvinyl polymer - 2.0 g X of magnesium silicate-colloidal aluminum - 1.0 g% of oxyethylene polymer - qsq PH 4 , 5 of sodium hydroxide 1N - 5.0 g% of HDP - 0.025 g% of saccharin of Arbyldimethylbenzylammonium - 0.5 g% of known preservative "Nuosept C" (registered trademark) - qs 100 X of purified water
Example 3
Hydroalcoholic lotion comprising - 5.0 g% HDP - 0.03 g% alroyl dimethylbenzylammonium saccharinate - 4.9 g% capric acid glyceride (polyoxyethylene capric ester
glycol) - 1.5 g% glycerin - 35.0 g% purified water - 0.5 g% citric acid - 58.0 g of 960 alcohol - 0.6 g% of Germal II preservative - perfume qs for 100%
Example 4
Dermal cream comprising - 5 g% HDP - 0.025 g% akcyldimethylbenzylammonium saccharinate - 6 g% polyoxyethylene lauryl ether (laureth-23 type) - 2 g% carboxyvinyl polymer - 2 g% titanium oxide - 5 g% acetone - 0.5 g% NuoseptC preservative - qsq PH 4.5 of triethanolamine - qs 100% purified water
Example 5
Aqueous suspension comprising - 5 g% of HDP - 1 g% of propylene glycol - 2 g% of diethanolamide of coconut fatty acid - 0.025 g% of saccharinate draR yldimethylbenzylammonium - 0.8 g% of magnesium aluminum silicate - 0.9 g% sodium chloride - lg% hydroxypropyl methylcellulose - 0.5 g X of Nuoseptic preservative - qs 100% distilled water
EXAMPLE 6 Foaming Shaving Cream of Composition - 5.0 g X of HDP - 20.0 g X of stearic acid - 10.0 g% of lauric acid - 2.0 g X of sodium hydroxide - 1 , 0 g% potassium hydroxide - 10.0 g% glycerin - 1.0 g% lanolin - 2.0 g X vegetable oil - 0.5 g X imidazolidinylurea (preservative) - qsg water purified 100 g
Example 7
Shaving balm comprising - 5.0 g% HDP - 0.025 g X aloyl dimethylbenzyl ammonium saccharinate - 7.0 g% peanut oil - 0.66 g% perfume - 0.4 g% of triethanolamine l, lg% of ammonia - 16.6 g% of stearin - qs 100% of purified water Example 8::
Hydroalcoholic lotion comprising - 5.0 g% HDP - 0.6 g X of Germal II preservative - 5.0 g X of Ameroxol OE 10 (methoxylated oleic alcohol) - 2.5 g X of Glucam E 20 (glucoside niethoxyle) - 45.0 g X ethyl alcohol 950 qs 100 X purified water
example 9
We get watery against razor fire including
- 1.25 g of pistocstne (oxy-polyethoxydodecane)
- 1.00 g of stearic acid
- 0.50 g of triethanolamime
- 0.90 g of Lanol CTO wax
- 5 g of freon (40/60 mixture of freon 12 and freon 114)
- qs 100 Z or 25 g of purified water.
Des experimentations ont été effectuées sur les propriétés cosmétopharmacologiques des formulations ci-dessus selon l'invention en soumettant ces dernières à des essais sur des utilisateurs. Il a été constaté que ces derniers, soumis au traitément, ne se plaignaient pas de douleurs et/ou de brûlures, tant dans les premières minutes de la séance de traitement que plus tard. Experiments were carried out on the cosmetopharmacological properties of the above formulations according to the invention by subjecting the latter to tests on users. It was found that the latter, subject to treatment, did not complain of pain and / or burns, both in the first minutes of the treatment session and later.
La composition selon l'invention a été administrée par application sous forme de massage sur la peau à traiter, quelques minutes avant l'opération, sans que les utilisateurs aient eu à aubir les inconvénients des traitements anesthésiques. The composition according to the invention was administered by application in the form of a massage on the skin to be treated, a few minutes before the operation, without the users having had to overcome the drawbacks of anesthetic treatments.
Par exemple, des essais cliniques effectués en double insu et comparant la composition de baume selon l'exemple 7 à une composition placebo, ont montré la supériorité de la composition de l'invention
sur le traitement de comparaison, en particulier du point de vue de la
tolérance et de la douleur ressentie lors des séances d'épilation et de
rasage. For example, double-blind clinical trials comparing the balm composition according to Example 7 to a placebo composition have shown the superiority of the composition of the invention
on the comparison treatment, in particular from the point of view of
tolerance and pain experienced during hair removal and
shaving.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8811318A FR2635682A1 (en) | 1988-08-29 | 1988-08-29 | Cosmetic composition for application to the skin for reducing the burning sensation on shaving or depilation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8811318A FR2635682A1 (en) | 1988-08-29 | 1988-08-29 | Cosmetic composition for application to the skin for reducing the burning sensation on shaving or depilation |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2635682A1 true FR2635682A1 (en) | 1990-03-02 |
Family
ID=9369567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8811318A Pending FR2635682A1 (en) | 1988-08-29 | 1988-08-29 | Cosmetic composition for application to the skin for reducing the burning sensation on shaving or depilation |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2635682A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1332752A1 (en) * | 2002-01-31 | 2003-08-06 | Robert Benjamin Norburn | Shaving, after-shave and skin conditioning compositions |
EP1779898A1 (en) | 2005-10-27 | 2007-05-02 | McNeil-PPC, Inc. | Method of epilation |
WO2009051486A1 (en) * | 2007-10-18 | 2009-04-23 | Sara Lee/De N.V. | Shaving composition with skincare properties |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3314857A (en) * | 1964-07-29 | 1967-04-18 | Clairol Inc | Shaving assistant composition |
US3734858A (en) * | 1971-01-20 | 1973-05-22 | Witco Chemical Corp | Pre-electric shave compositions |
US4279891A (en) * | 1979-02-08 | 1981-07-21 | American Cyanamid Company | Low alcohol content after-shave lotion |
US4394381A (en) * | 1979-04-13 | 1983-07-19 | George F. And Irene Sherrill 1978 Trust No. 1 | Method for the relief of pain |
EP0197876B1 (en) * | 1985-03-26 | 1990-07-11 | Anben | Therapeutical composition for use in dermatology containing imidazolidinyl urea as an active substance |
-
1988
- 1988-08-29 FR FR8811318A patent/FR2635682A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3314857A (en) * | 1964-07-29 | 1967-04-18 | Clairol Inc | Shaving assistant composition |
US3734858A (en) * | 1971-01-20 | 1973-05-22 | Witco Chemical Corp | Pre-electric shave compositions |
US4279891A (en) * | 1979-02-08 | 1981-07-21 | American Cyanamid Company | Low alcohol content after-shave lotion |
US4394381A (en) * | 1979-04-13 | 1983-07-19 | George F. And Irene Sherrill 1978 Trust No. 1 | Method for the relief of pain |
EP0197876B1 (en) * | 1985-03-26 | 1990-07-11 | Anben | Therapeutical composition for use in dermatology containing imidazolidinyl urea as an active substance |
Non-Patent Citations (2)
Title |
---|
S.T.N., Serveus Kahslruche, RFA, Base de domnées: "Registry" * |
THE MERCK INDEX: "An encyclopedia of chemicals, drugs, and biologicals", 10eme edition, 1983, page 1090, Merck & Co., Inc., Rahway, US * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1332752A1 (en) * | 2002-01-31 | 2003-08-06 | Robert Benjamin Norburn | Shaving, after-shave and skin conditioning compositions |
US7354573B2 (en) | 2002-01-31 | 2008-04-08 | Norburn Robert B | Shaving, after-shave, and skin conditioning compositions |
EP1779898A1 (en) | 2005-10-27 | 2007-05-02 | McNeil-PPC, Inc. | Method of epilation |
WO2009051486A1 (en) * | 2007-10-18 | 2009-04-23 | Sara Lee/De N.V. | Shaving composition with skincare properties |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0493151B1 (en) | Slimming composition containing ginkgo biloba as alpha-2 blocker | |
CA2151422C (en) | Milky oil-in-water cleaning emulsion | |
CA2312528C (en) | Cosmetic toning compound containing at least one hydroxystilbene in association with ascorbic acid | |
CA1138739A (en) | Make up remover for the face and eyes | |
JP3411040B2 (en) | Use of at least one cutibilinaceae extract in a composition | |
FR2721210A1 (en) | Cleaning composition containing lipid grains. | |
LU85111A1 (en) | ANTI-ACNETIC COMPOSITION BASED ON BENZOYL PEROXIDE AND AT LEAST ONE SOLAR FILTER | |
BE898268A (en) | New anti-acne composition based on benzoyl peroxide and at least one other active ingredient. | |
EP0780114A1 (en) | Transparent nanoemulsion based on silicon tensio actives and its use in cosmetics or in dermopharmaceutics | |
EP0681827B1 (en) | Use of bioflavonoids as protecting agent for keratin materials | |
FR2787323A1 (en) | USE OF N-ACYL COMPOUNDS OF AMINO ACIDS AS A TEXTURING AGENT | |
EP0716849A1 (en) | Cosmetic or dermatological composition containing a mixture of ceramides and its use for moisturizing the skin | |
FR2478485A1 (en) | COSMETIC OR PHARMACEUTICAL COMPOSITIONS IN THE FORM OF STABLE EMULSIONS OF THE OIL-IN-WATER TYPE | |
CA2216569C (en) | Use of oxazolidinone derivatives as anti-penetrating agents in a cosmetic and/or dermatological composition | |
EP0655235A1 (en) | Slimming composition | |
CA2099473C (en) | Depigmenting cosmetic and/or dermatologic composition containing a di- or tri-cafeoylquinic acid or a blend of these acids | |
EP0835652B1 (en) | Use of at least one glycol in the solubilisation of melatonin in water and compositions containing them | |
EP1110538A2 (en) | Cosmetic composition comprising an aminophenol derivative | |
FR2635682A1 (en) | Cosmetic composition for application to the skin for reducing the burning sensation on shaving or depilation | |
EP0688561B2 (en) | Oily peeling gel | |
FR2802096A1 (en) | Topical compositions comprising pentacyclic triterpene acid and a fatty acid monoester emulsifying agent, are used for treatment of acne, erythema, photo-aging or protection of sensitive skin | |
FR2758724A1 (en) | Controlling cellulite and fat deposition | |
EP0223671A1 (en) | Medicament with a synergistic anti-inflammatory effect on the basis of a corticosteroid and a beta-agonist | |
CA1314815C (en) | Nail emollient compound | |
EP0197876B1 (en) | Therapeutical composition for use in dermatology containing imidazolidinyl urea as an active substance |